Health tech companies to share £1.7m

Three Scottish health technology companies are to share more than £1.7 million in research funding.

The UK Government grants are part of a programme to improve patient outcomes in health and social care.

RoslinCT in Edinburgh has been awarded £887,000 to develop stem cell therapies for clinical use, while Storm, based in Edinburgh and Glasgow, received £586,000 to work on digital services for patients with lung conditions.

Daysix, which has centres in Edinburgh and Glasgow has also been awarded £290,000 to develop a clinical decision support app for trauma care.

UK Business Secretary Greg Clark said: “Technology is revolutionising industries across our economy, and new innovations play a key role in advancing our healthcare sector to make sure people are living longer, healthier and happier lives.

“By pooling the expertise of the public and private sectors, as highlighted through the Life Sciences Sector Deal and the modern Industrial Strategy, we are making every opportunity to reach our full potential in finding new discoveries and technologies to diagnose illnesses earlier that could lead to more lives being saved.”

Scotland Office minister Lord Duncan said: “This UK Government funding is about supporting breakthrough technologies to transform healthcare across the country for both patients and staff.

“Three Scottish companies will receive more than £1.7 million to develop cell-based therapeutics, digital self-management services for lung patients and systems to provide real-time decision support in the care of trauma patients.

“Scottish companies are at the forefront of life science developments, and this UK Government funding will help them develop their expertise even further.”